- 基本信息
导师姓名:
|
刘颖斌
|
学科代码:
|
100210
|
|
性别:
|
男
|
学科名称:
|
外科学
|
培养单位:
|
附属仁济医院
|
三级学科
|
普外
|
导师类型:
|
博士生导师
|
专业领域名称:
|
外科学 专业学位
|
联系方式:
|
上海交通大学医学院附属仁济医院胆胰外科
|
专业领域代码:
|
105111
|
邮编:
|
200127
|
邮箱地址:
|
laoniulyb@163.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
|
肝胆胰外科杂志、浙江临床医学杂志特约编委
|
中华医学会肝脏学组委员
|
上海医师协会普外科专业委员会副会长
|
中华医学会肿瘤分会胰腺学组、胃肠学组委员
|
中华外科杂志通讯编委
|
中国实用外科杂志、外科理论与实践杂志、世界胃肠病学杂志、实用肿瘤杂志、华人消化外科杂志编委
|
中国抗癌协会胆道癌、胰腺癌专业委员会委员
|
上海市医学会普外科专业委员会副主任委员
|
上海医学会(普外)委员兼秘书
|
上海市医学会普外科专业委员会胆道学组组长
|
中华医学杂志、中华外科学杂志、中华普通外科杂志、中华实验外科杂志特约编委
|
中国医师学会普外科专业委员会委员
|
国家自然科学基金、教育部科技奖励评审专家
|
上海外科学会普外科分会胰腺学组副组长
|
- 科研项目
3213000192 | 基于组学的胆道恶性肿瘤分子免疫全景解析 | 国家自然科学基金重点项目 |
2022-01~2026-12
|
308.1万元
| 课题负责人 |
20JC1419101 | 胆道肿瘤分子特征谱及系统功能组学研究 | 上海市科委 |
2020-10~2023-09
|
220万元
| 子课题负责人 |
2019XH004 | 非编码RNA在癌细胞及其微环境共进化中的功能机制 | 国家自然科学基金集成项目 |
2020-01~2022-12
|
150万元
| 课题负责人 |
YDZX20193100004049 | 长三角区域胆石症与胆道肿瘤相关性研究以及胆道肿瘤个体化诊治方案制定 | 上海市科委项目 |
2019-09~2022-08
|
150万元
| 课题负责人 |
2019ZX09301-158 | 多激酶抑制剂TT-00420的临床前与多中心篮式临床研究 | 科技部新药创制项目 |
2019-01~2020-12
|
677万元
| 课题负责人 |
81874181 | 外泌体介导的LncRNA-LINC00239在胆囊癌侵袭转移中的作用机制研究 | 国家自然科学基金面上项目 |
2019-01~2022-12
|
58万元
| 课题负责人 |
SHDC12018107 | Afatinib联合Nivolumab治疗ERBB2/3突变型胆囊癌有效性、安全性的多中心、随机对照研究 | 上海市级医院新兴前沿项目 |
2018-11~2021-11
|
150万元
| 课题负责人 |
31620103910 | LINC01605 调控胆囊癌干细胞自我更新的功能和机制研究 | 国家自然科学基金国际合作项目 |
2017-01~2020-12
|
256万元
| 课题负责人 |
16JC1400200 | 基于hiHep细胞的生物人工肝支持系统的临床应用研究 | 上海市科委重大基础研究项目
|
2016-07~2019-06
|
780万元
| 课题负责人 |
16411952501 | 兼具胆管癌早期影像诊断及基因治疗功能的靶向纳米材料研发 | 上海市科委生药处重点项目 |
2016-07~2019-09
|
38万元
| 课题负责人 |
DLY201507 | 胆囊癌恶性靶向治疗多中心临床研究 | 上海交通大学医学院多中心临床研究项目
|
2015-12~2017-12
|
200万元
| 课题负责人 |
15ZH4003 | 胆囊癌靶向治疗多中心临床研究 | 上海交通大学医学院转化医学创新基金(第二期)——精准医学研究项目
|
2015-09~2017-08
|
100万元
| 课题负责人 |
91440203 | LncRNA-LINC01133作用机制以及在胆囊癌中功能研究 | 国家自然基金重大项目 |
2015-01~2018-12
|
300万元
| 课题负责人 |
SHDC12014109 | 胰头癌全系膜切除技术的解剖和临床应用研究 | 申康 |
2014-10~2017-09
|
120万元
| 课题负责人 |
20130073130014 | 基于vimentin构建胆囊癌术后复发转移早期识别的靶向性纳米磁共振造影剂的研发 | 高等学校博士学科点专项科研基金(优先发展领域) |
2014-01~2016-12
|
40万元
| 课题负责人 |
12JC1406700 | miR-203在胃癌发生和转移过程中的机制研究 | 上海市科委基础重点项目(连续资助项目) |
2013-01~2015-12
|
40万元
| 课题负责人 |
81272402 | ceRNA调控分子群在胆囊癌细胞转移可塑性中的分子机制研究 | 国家自然科学基金面上项目 |
2013-01~2016-12
|
75万元
| 课题负责人 |
SS2012AA023706 | 胆囊癌复发转移识别的高敏分子超声影像技术研发 | 863国家科技重大专项 |
2012-11~2015-12
|
420万元
| 课题负责人 |
12410705900 | FN介导的胆囊癌细胞转移和耐药现象的机制研究 | 2012年上海市科委政府间国际合作项目 |
2012-10~2014-09
|
50万元
| 课题负责人 |
81172029 | ZFX基因调控胆囊癌EMT的功能研究 | 国家自然科学基金面上项目 |
2012-01~2014-12
|
55万元
| 课题负责人 |
20110073110086 | Vimentin与胆囊癌侵袭转移的相关性研究 | 高等学校博士学科点专项科研基金资助课题名单(博导类) |
2012-01~2013-12
|
12万元
| 课题负责人 |
11XD1403800 | 胆囊癌侵袭转移相关优势亚功能单位的筛选 | 上海市科委 |
2012-01~2014-12
|
40万元
| 课题负责人 |
C160402 | 胆囊癌细胞亚群的克隆分选及异质性分析 | 国家自然基金面上项目 |
2010-01~2012-12
|
32万元
| 课题负责人 |
30972918 | 胆囊癌细胞亚群的克隆分选及异质型分析 | 国家自然科学基金面上项目 |
2010-01~2012-12
|
32万元
| 课题负责人 |
- 学术论文
Yijian Zhang , Chunman Zuo, Liguo Liu , Yunping Hu , Bo Yang, Shimei Qiu, Yang Li, Dongyan Cao, Zheng Ju, Jing Ge , Qiu Wang, Ting Wang, Lu Bai, Yang Yang , Guoqiang Li, Ziyu Shao, Yuan Gao, Yongsheng Li, Rui Bian, Huijie Miao, Lin Li, Xuechuan Li, Chengkai Jiang, Siyuan Yan , Ziyi Wang, Zeyu Wang, Xuya Cui, Wen Huang, Dongxi Xiang , Congjun Wang, Qiyun Li, Xiangsong Wu, Wei Gong, Yun Liu , Rong Shao, Fatao Liu , Maolan Li, Luonan Chen,
|
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer
|
Journal of Hepatology
|
2021
|
Online ahead of print
|
Fatao Liu,Yongsheng Li,Dongjian Ying,Shimei Qiu,Yong He,Maolan Li,Yun Liu, Yijian Zhang, Qin Zhu,Yunping Hu,Liguo Liu,Guoqiang Li,Weihua Pan,Wei Jin,Jiasheng Mu,Yang Cao,
|
Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder
|
Signal transduction and targeted therapy
|
2021
|
6: 55
|
Yijian Zhang, Pengcheng Du, Yang Li, Qin Zhu, Xiaoling Song, Shibo Liu, Jiaqi Hao, Liguo Liu, Fatao Liu, Yunping Hu, Lin Jiang, Qiang Ma, Wei Lu,
|
TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway
|
International Journal of Biological Sciences
|
2020
|
16(5): 739-751
|
Xiaoling Song,Yunping Hu,Yongsheng Li,Rong Shao, Fatao Liu,
|
Overview of current targeted therapy in gallbladder
|
Signal transduction and targeted therapy
|
2020
|
5(1): 1-19
|
Xiaoling Song, Xu'an Wang, Yunping Hu, Huaifeng Li, Tai Ren, Yongsheng Li, Liguo Liu, Lin Li, Xuechuan Li, Ziyi Wang, Wen Huang, Runfa Bao, Yijian Zhang, Maolan Li, Xuefeng Wang, Feng Liu, Jun Gu, Linhui Zheng, Wenguang Wu,
|
A metagenomic study of biliary microbiome change along the cholecystitis-carcinoma sequence
|
Clin Transl Med
|
2020
|
10.1002
|
? YunPing Hu, YunPeng Jin, XiangSong Wu, Yang Yang, YongSheng Li, HuaiFeng Li, ShanShan Xiang, XiaoLing Song, Lin Jiang, YiJian Zhang, Wen Huang, ShiLi Chen, FaTao Liu, Chen Chen, Qin Zhu, HongZhuan Chen, Rong Shao,
|
LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis
|
Molecular Cancer
|
2019
|
18(1)
|
Maolan Li, Fatao Liu, Fei Zhang, Weiping Zhou, Xiaoqing Jiang, Yuan Yang, Kai Qu, Yueqi Wang, Qiang Ma, Ting Wang, Lu Bai, Zheng Wang, Xiaoling Song, Yidi Zhu, Ruiyan Yuan, Yuan Gao, Yongchen Liu, Yunpeng Jin, Huaifeng Li, Shanshan Xiang, Yuanyuan Ye, Yijian Zhang, Lin Jiang, Yunping Hu, Yajuan Hao, Wei Lu, Shili Chen, Jun Gu, Jian Zhou, Wei Gong, Yong Zhang, Xuefeng Wang, Xiyong Liu, Chang Liu, Houbao Liu, Yun Liu & Yingbin Liu.
|
Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.
|
Gut
|
2019
|
68(6):1024-1033
|
Shanshan Xiang, Zheng Wang, Yuanyuan Ye, Fei Zhang, Huaifeng Li, Yang Yang, Huijie Miao, Haibin Liang, Yijian Zhang, Lin Jiang, Yunping Hu, Lei Zheng, Xiyong Liu,
|
E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer.
|
Oncogenesis
|
2019
|
38:1269-1281
|
Yunpeng Jin, Yunping Hu, Xiangsong Wu, Yaoshi Wu, Yuanyuan Ye, Huaifeng Li, Yongchen Liu, Lin Jiang, Fatao Liu, Yijian Zhang, Yajuan Hao,
|
miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.
|
Cell Death & Disease
|
2018
|
9, 182
|
Yuanyuan Ye, Jiawei Mei, Shanshan Xiang, Huaifeng Li, Qiang Ma, Xiaoling Song, Zheng Wang, Yichi Zhang, Yongchen Liu, Yunpeng Jin, Yunping Hu, Lin Jiang, Fatao Liu, Yijian Zhang, Yajuan Hao & Yingbin Liu
|
MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7.
|
Cell Death & Disease
|
2018
|
9, 410
|
Li M, Liu F, Zhang F, Zhou W, Jiang X, Yang Y, Qu K, Wang Y, Ma Q, Wang T, Bai L, Wang Z, Song X, Zhu Y, Yuan R, Gao Y, Liu Y, Jin Y, Li H, Xiang S, Ye Y, Zhang Y, Jiang L, Hu Y, Hao Y, Lu W, Chen S, Gu J, Zhou J, Gong W, Zhang Y, Wang X, Liu X, Liu C, Liu H, Liu Y,
|
Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.
|
Gut
|
2018
|
doi: 10.1136/gutjnl-2018-316039
|
Yuanyuan Ye, Jiawei Mei, Shanshan Xiang, Huaifeng Li, Qiang Ma, Xiaoling Song, Zheng Wang, Yichi Zhang, Yongchen Liu, Yunpeng Jin, Yunping Hu, Lin Jiang, Fatao Liu, Yijian Zhang, Yajuan Hao & Yingbin Liu.
|
MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7
|
Cell Death & Disease
|
2018
|
9, 410.
|
Zhang F, Xiang S, Cao Y, Li M, Ma Q, Liang H, Li H, Ye Y, Zhang Y, Jiang L, Hu Y, Zhou J, Wang X, Zhang Y, Nie L, Liang X, Gong W,
|
EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway.
|
Cell Death & Disease
|
2017
|
8(6):e2868
|
Xiangsong Wu, Fang Wang, Huaifeng Li, Yunping Hu, Lin Jiang, Fei Zhang, Maolan Li, Xu’an Wang, Yunpeng Jin, Yijian Zhang, Wei Lu, Wenguang Wu, Yijun Shu, Hao Weng, Yang Cao, Runfa Bao, Haibin Liang, Zheng Wang, Yichi Zhang, Wei Gong, Lei Zheng, Shuhan Sun & Yingbin Liu
|
LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis.
|
EMBO Rep
|
2017
|
18(10), 1837-1853
|
Yijun Shu, Runfa Bao, Lin Jiang, Zheng Wang, Xu-An Wang, Fei Zhang, Hanbin Liang, Huaifeng Li, Yuanyuan Ye, Shanshan Xiang, Hao Weng, Xiangsong Wu, Maolan Li, Yunping Hu, Wei Lu, Yijian Zhang, Jian Zhu, Ping Dong and Ying-Bin Liu
|
MicroRNA-29c-5p Suppresses Gallbladder Carcinoma Progression by Directly Targeting CPEB4 and Inhibiting the MAPK Pathway
|
Cell Death and Differentiation
|
2017
|
doi: 10.1038/cdd.2016.146
|
Maolan Li, Fatao Liu, Yijian Zhang, Xiangsong Wu, Wenguang Wu, Xu-An Wang, Shuai Zhao, Shibo Liu, Haibin Liang, Fei Zhang, Qiang Ma, Shanshan Xiang, Huaifeng Li, Lin Jiang, Yunping Hu, Wei Gong, Yun Zhang, Tieliang Ma, Kai Zhang, Yun Liu,
|
Whole-genome sequencing reveals the mutational landscape of metastatic small-cell gallbladder neuroendocrine carcinoma (GB-SCNEC)
|
Cancer letters
|
2017
|
391: 20–27
|
Zhang F, Ma Q, Xu Z, Liang H, Li H, Ye Y, Xiang S, Zhang Y, Jiang L, Hu Y, Wang Z, Wang X, Zhang Y, Gong W,
|
Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
|
J Exp Clin Cancer Res
|
2017
|
36(1):68
|
Yang Cao, Haibin Liang, Fei Zhang, Zhou Luan, Shuai Zhao, Xu-an Wang, Shibo Liu, Runfa Bao, Yijun Shu, Qiang Ma, Jian Zhu,
|
Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer
|
Journal of Experimental & Clinical Cancer Research
|
2016
|
35:68
|
Shuai Zhao, Yang Cao, Shibo Liu, Xu-an Wang, Runfa Bao, Yijun Shu, Yunping Hu, Yijian Zhang, Lin Jiang, Fei Zhang, Haibin Liang, Huaifeng Li, Qiang Ma, Yi Xu, Zheng Wang, Yichi Zhang, Lei Chen, Jian Zhou,
|
The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR
|
Journal of Experimental & Clinical Cancer Research
|
2016
|
35:97
|
Cao Y, Liu X, Lu W, Chen Y, Wu X, Li M, Wang X-a, Zhang F, Jiang L, Zhang Y, Hu Y, Xiang S, Shu Y, Bao R, Li H, Wu W, Weng H, Yen Y,
|
Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer
|
Cancer letters
|
2015
|
360(2):141-150
|
Shu Y, Weng H, Ye Y, Hu Y, Bao R, Cao Y, Wang X, Zhang F, Xiang S, Li H, Wu X, Li M, Jiang L, Lu W, Han B, Jie Z,
|
SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway
|
Molecular cancer
|
2015
|
14(1):1-14
|
Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, Liu C, Shen B, Wang XA, Wu W, Zhou D, Zhang D, Wang T, Liu B, Qu K, Ding Q, Weng H, Ding Q, Mu J, Shu Y, Bao R, Cao Y, Chen P, Liu T, Jiang L, Hu Y, Dong P, Gu J, Lu W, Shi W, Lu J, Gong W, Tang Z, Zhang Y, Wang X, Chin YE, Weng X, Zhang H, Tang W, Zheng Y, He L, Wang H, Liu Y,
|
Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.
|
Nature Genetics
|
2014
|
2014(46):872-876
|
? Maolan Li, Jianhua Lu, Fei Zhang, Huaifeng Li, Bingtai Zhang, Xiangsong Wu, Zhujun Tan, Lin Zhang, Guofeng Gao, Jiasheng Mu, Yijun Shu, Runfa Bao, Qichen Ding, Wenguang Wu, Ping Dong, Jun Gu & Yingbin Liu.
|
Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway
|
Cancer letters
|
2014
|
355, 201-209
|
Quan Z, Gu J, Dong P, Lu J, Wu X, Wu W, Fei X, Li S, Wang Y, Wang J,
|
Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells
|
Cancer Lett
|
2010
|
295(2):252-9
|
Li S, Dong P, Wang J, Zhang J, Gu J, Wu X, Wu W, Fei X, Zhang Z, Wang Y, Quan Z,
|
Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway.
|
Cancer Lett.
|
2010
|
298(2):222-30
|
|